New research explores hydrogen sulfide as treatment for obesity

Therapies that deliver hydrogen sulfide to cells could one day become the basis of new treatments for obesity and related diseases, new research has concluded.

Novo and Viking present new MASH data, but analysts remain confident in Madrigal’s Rezdiffra

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 21, 2024

At-Home Treatment for Molluscum Contagiosum Wins FDA Approval

The FDA approved the first at-home topical therapy for molluscum contagiosum, a highly contagious viral skin infection that primarily affects children. The approval of berdazimer

January 9, 2024

FDA warns BD blood culture bottle shortage could impact diagnosis

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Disruption to the supply of

July 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.